Adjuvant medications that improve survival after locoregional therapy

PURPOSE: To determine if outpatient medications taken at the time of liver tumor embolization or ablation affect survival. METHODS: An IRB-approved retrospective review was performed of 2032 liver tumor embolization, radioembolization, and ablation procedures on 1092 patients from June 2009 to April...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Vasc Interv Radiol
Glavni autori: Boas, F. Edward, Ziv, Etay, Yarmohammadi, Hooman, Brown, Karen T., Erinjeri, Joseph P., Sofocleous, Constantinos T., Harding, James J., Solomon, Stephen B.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5502720/
https://ncbi.nlm.nih.gov/pubmed/28527884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2017.04.016
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items